Nurses at a Massachusetts hospital that required COVID-19 vaccination as a condition of employment are sounding the alarm after a disturbing cluster of brain cancer diagnoses among longtime staff.
At least ten nurses from the fifth-floor maternity ward at Newton-Wellesley Hospital have been diagnosed in recent years with glioblastoma and other aggressive brain tumors, according to a report by CBS News reported.
“You’re going into work every day with that feeling in your gut, and it’s a lousy feeling,” one of the nurses diagnosed with a brain tumor told WBZ-TV. “It’s getting to the point where the number just increases, and you start saying am I crazy thinking this,” she said. “This can’t just be a coincidence.”
Hospital officials said an internal investigation found no environmental hazards, but the cases have drawn national attention—and renewed scrutiny of the possible connection between mRNA COVID-19 vaccines and a concerning rise in fast-growing, treatment-resistant cancers.
Known informally as “turbo cancers,” these rapidly emerging malignancies have been described by physicians as biologically distinct from traditional cancers—appearing suddenly, progressing at unusual speed, and often presenting at late stages in individuals with no prior cancer history. According to a detailed analysis by The Epoch Times, numerous oncologists and pathologists have observed these patterns in clinical practice, often following COVID-19 vaccination.
“What’s happening is these cancers we’re used to seeing—their growth patterns and behavior are completely out of character,” said Dr. Ryan Cole, a pathologist and CEO of Cole Diagnostics. “So ‘turbo cancer’ is something that wasn’t there and, all of a sudden, it’s everywhere.”
Dr. Cole and other researchers believe that repeated exposure to the spike protein via mRNA vaccines may interfere with the body’s natural immune surveillance mechanisms, allowing cancerous cells to escape detection and multiply unchecked. A Belgian study cited in The Epoch Times reported malignant lymphoma developing in lab mice shortly after receiving a Pfizer booster. Multiple case reports have documented similar events in human patients—some developing lymphoma, others breast cancer or other tumors—within weeks or months of vaccination.
In one case, a 66-year-old man developed swollen lymph nodes ten days after his third Pfizer dose and was subsequently diagnosed with stage 2 non-Hodgkin lymphoma. Another report documented a healthy 39-year-old woman who experienced lymphadenopathy following her Pfizer shot. Six months later, she was diagnosed with invasive breast cancer in the same area of the body where the vaccine was administered.
Experts say the underlying mechanism of turbo cancers remains unclear but point to several possibilities. These include suppression of tumor-fighting T-cells, interference with DNA repair, altered expression of antibody subclasses, and even the potential integration of vaccine-derived genetic material into the human genome. Some researchers have raised concerns about plasmid DNA contamination and the presence of SV40—a known oncogenic virus—in vaccine vials.
Dr. William Makis, an oncologist and nuclear medicine specialist, emphasized the urgency of understanding this phenomenon. “At this time, oncologists have nothing to offer patients who have developed a turbo cancer,” he said. “Conventional cancer treatments offer minimal or no benefit.”
While official health agencies like the CDC and FDA continue to assert the safety of COVID-19 vaccines, internal data suggests they are aware of potential red flags. Research scientist David Wiseman and colleagues submitted a 27-page report to the National Academies Committee documenting an excess of cancer-related safety signals associated with mRNA vaccines. Using data from the Vaccine Adverse Event Reporting System, the team identified disproportionate reports of colon cancer, metastatic breast cancer, lymphomas, and other malignancies following COVID-19 shots, compared to all other vaccines since 1990.
Proportional Reporting Ratio analyses conducted by the CDC—and obtained through a Freedom of Information Act request—support these findings, identifying cancer-related safety signals that appear statistically significant.
Despite this, no large-scale, independent studies have been launched to examine the connection between mRNA vaccines and cancer. Pharmaceutical companies were not required to evaluate the long-term carcinogenic potential of their products prior to emergency use authorization. Critics say this lack of due diligence, combined with widespread mandates and censorship of dissenting voices, has made it nearly impossible to raise safety concerns without professional or social consequences.
Whether or not the cancers among Newton-Wellesley nurses are ultimately linked to COVID-19 vaccination, many believe the timing and concentration of cases deserve a closer look. And with growing anecdotal and clinical reports of turbo cancers appearing in previously healthy individuals across the country, pressure is mounting for public health authorities to stop dismissing concerns and start investigating them.
